Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML
The oncogene MLL is frequently translocated in leukemia, resulting in oncogenic fusion proteins. Here, the authors report a temporally controlled mouse model of MLL-ENL driven leukemia AND identify therapeutic targets associated with early MLL-ENL driven leukaemogenesis.
Enregistré dans:
Auteurs principaux: | Silvia Basilico, Xiaonan Wang, Alison Kennedy, Konstantinos Tzelepis, George Giotopoulos, Sarah J. Kinston, Pedro M. Quiros, Kim Wong, David J. Adams, Larissa S. Carnevalli, Brian J. P. Huntly, George S. Vassiliou, Fernando J. Calero-Nieto, Berthold Göttgens |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f3f11e1f04f14988aa6abc97b3c99275 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
par: Yue Sheng, et autres
Publié: (2020) -
Selective binding of the PHD6 finger of MLL4 to histone H4K16ac links MLL4 and MOF
par: Yi Zhang, et autres
Publié: (2019) -
TARGETED THERAPY IN AML TREATMENT
par: Giovanni Martinelli
Publié: (2021) -
MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing.
par: Claudia V Andreu-Vieyra, et autres
Publié: (2010) -
AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicin.
par: David B Rosen, et autres
Publié: (2013)